Intestinal microbiota, obesity and prebiotics

• Autorzy: Barczynska R. , Bandurska K. , Slizewska K. , Litwin M. , Szalecki M. , Libudzisz J. , Kapusniak J.
• Języki publikacji: EN

Abstrakty

EN

Over the past few decades there has been a significant increase in the prevalence of obesity in both children and adults. Obesity is a disease that has reached epidemic levels on a global scale. The development of obesity is associated with both environmental and genetic factors. Recent studies indicate that intestinal microorganisms play an important function in maintaining normal body weight. One of the objectives in the gut microbiota research is to determine the role it plays and can it be a reliable biomarker of disease risk, including the predisposition to obesity. This article discusses (1) the role of prebiotics and gut microbiota in maintaining a healthy body weight and (2) potential influence on the gut microbiota in the prevention and treatment of obesity.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2015
• Tom: 64
• Numer: 2
• Opis fizyczny: p.93-100,fig.,ref.

Twórcy

autor

Barczynska R.

• Institute of Chemistry, Environmental Protection and Biotechnology, Jan Dlugosz University in Czestochowa, Czestochowa, Poland

autor

Bandurska K.

• Institute of Chemistry, Environmental Protection and Biotechnology, Jan Dlugosz University in Czestochowa, Czestochowa, Poland

autor

Slizewska K.

• Institute of Fermentation Technology and Microbiology, Faculty of Biotechnology and Food Sciences, Technical University of Lodz, Lodz, Poland

autor

Litwin M.

• The Children’s Memorial Health Institute, Warsaw, Poland

autor

Szalecki M.

• The Children’s Memorial Health Institute, Warsaw, Poland
• Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland

autor

Libudzisz J.

• Institute of Fermentation Technology and Microbiology, Faculty of Biotechnology and Food Sciences, Technical University of Lodz, Lodz, Poland

autor

Kapusniak J.

• Institute of Chemistry, Environmental Protection and Biotechnology, Jan Dlugosz University in Czestochowa, Czestochowa, Poland

Bibliografia

• Abell G.C.J, C.M. Cooke, C.N. Bennett, M.A. Conlon and A.L. McOrist. 2008. Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol. Ecol. 66: 505–515.
• Alvarez-Castro P., L. Pena and F. Cordido. 2012. Ghrelin in obesity, physiological and pharmacological considerations. Mini-Rev. Med. Chem. 13(4): 541–552.
• Amar J., C. Chabo, A. Waget, P. Klopp, C. Vachoux, L.G. Bermudez-Humaran, N. Smirnova, M. Berge, T. Sulpice, S. Lahtinen and others. 2011a. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3(9): 559–572.
• Amar J., M. Serino, C. Lange, C. Chabo, J. Iacovoni, S. Mondot, P. Lepage, C. Klopp, J. Mariette, O. Bouchez and others. 2011b. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54: 3055–3061
• Archer B.J., S.K. Johnson, H.M. Devereux and A.L. Baxter. 2004. Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, postmeal perceptions of satiety and food intake in men. Br. J. Nutr. 91(4): 591–599.
• Arumugam M., J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D.R. Mende, G.R. Fernandes, J. Tap, T. Bruls, J.M. Batto and others. 2011. Enterotypes of the human gut microbiome. Nature 473(7346): 174–180.
• Backhed F., H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, C.F. Semenkovich and J.I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl. Acad. Sci. 10: 15718–15723.
• Backhed F., J.K. Manchester, C.F. Semenkovich and J.I. Gordon. 2007. Mechanism underlying the resistance to diet-included in germ-free mice. Proc. Natl. Acad. Sci. 101: 15718–15723.
• Barczynska R., K. Slizewska, K. Jochym, J. Kapusniak and Z. Libudzisz. 2012. The tartaric acid-modified enzyme-resistant dextrin from potato starch as potential prebiotic. Journal of Functional Foods 4: 954–962.
• Barczynska R., K. Jochym, K. Śliżewska, J. Kapuśniak and Z. Libudzisz. 2010. The effect of citric acid-modified enzyme-resistant dextrin on growth and metabolism of selected strains of probiotic and other intestinal bacteria. Journal of Functional Foods 2: 126–133.
• Bates J.M., J. Akerlund, E. Mittge and K. Guillemin. 2007. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut mikrobiota. Cell Host Microbe 2: 371–382.
• Belenguer A., S.H. Duncan, A.G. Calder, G. Holtrop, P. Louis, G.E. Lobley and H.J. Flint. 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72: 3593–3599.
• Brinkworth G.D., M. Noakes, P.M. Clifton and A.R. Bird. 2009. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br. J. Nutr. 101: 1493–1502.
• Blaut M. and T. Clavel. 2007. Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr. 137: 751–755.
• Brun P., I. Castagliuolo, V.D. Leo, A. Buda, M. Pinzani, G. Palu and D. Martines. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. AJP – Gastrointestinal and Liver Physiology 292: 518–525.
• Cani P.D., C. Dewever and N.M. Delzenne. 2004. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 92(3): 521–526.
• Cani P.D., J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A.M. Neyrinck, F. Fava, K.M. Tuohy, C. Chabo and others. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7): 1761–1772.
• Cani P.D., R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, N.M. Delzenne and R. Burcelin. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470–1481.
• Cani P.D., S.Possemiers, W.T.Van, Y.Guiot, A.Everard, O.Rottier, L. Geurts, D. Naslain, A.M. Neyrinck, D.M. Lambert and others. 2009. Changes in gut microbiota con trol inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091–1103.
• Clausen M.R., H. Bonnén, M. Tvede and P.B. Mortensen. 1991. Colonic fermentation toshort-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 101: 1497–1504.
• De Filippo C., D. Cavalieri, M. Di Paola, M. Ramazzotti, J.B. Poullet, S. Massart, S. Collini, G. Pieraccini and P. Lionetti. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rual Africa. Proc. Natl. Acad. Sci. 107: 14694–14696.
• Delzenne N.M., P.D. Cani, C. Daubioul and A.M. Neyrinck. 2005. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93: 157–161.
• Delzenne N., A. Neyrinck and P.D. Cani. 2011. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microbial. Cell Factories 1: 1–11.
• Duncan S.H., P. Louis and H.J. Flint. 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70: 5810–5817.
• Duncan S.H., A. Belenguer, G. Holtrop, A.M. Johnstone, H.J. Flint and G.E. Lobley. 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Environ. Microbiol. 73: 1073–1078.
• DuPont A.W. and H.L. DuPont. 2011. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. 8: 523–531.
• Everard A., V. Lazarevic, M. Derrien, M. Girard, G.M. Muccioli, A.M. Neyrinck, S. Possemiers, A. Van Holle, P. François, W.M. de Vos and others. 2011. Responses of gut microbiota and glucose and lipid m etabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775–2786.
• Everard A., L.Geurts, M. VanRoye, N.M.Delzenne and P.D.Cani. 2012. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. Plos One 7: 33858.
• Everard A. and P.D. Cani. 2013. Diabetes, obesity and gut mikrobiota. Best Pract. Res. Clin. Gastroenterol 27: 1–3.
• FAO Technical Meeting on Prebiotics Food Quality and Standards Service (AGNS), Food and Agriculture Organization of the United Nations (FAO) FAO Technical meeting Report 2007, September, 15–16.
• Falony G., A. Vlachou, K. Verbrugghe and L. De Vuyst. 2006. Cross-feeding between Bifidobacterium longum BB536 and acetateconverting, butyrate-producing colon bacteria during growth on oligofructose. Environ. Microbiol. 72: 7835–7841.
• Feng T., L. Wang, T.R. Schoeb, C.O. Elson and Y. Cong. 2010. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207: 1321–1332.
• Fichna P. and B. Skowrońska. 2006. Complications of obesity in children and adolescents (in Polish). Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego 12 (3): 223–228.
• Fleissner C.K., N. Huebel, M.M. Abd El-Bary, G. Loh, S. Klaus and M. Blaut. 2010 Absence of intestinal microbiota does not protect mice from died-induced obesity. Br. J. Nutr. 104: 919–929.
• Geurts L., V. Lazarevic, M. Derrien, A. Everard, M. Van Roye, C. Knauf, P. Valet, M. Girard, G.G. Muccioli, P. François and others. 2011. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers Microbiol. 2: 149.
• Gao Z., J. Yin, J. Zhang, R.E. Ward, R.J. Martin, M. Lefevre, W.T. Cefalu and J. Ye. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509–1517.
• Hildebrandt M.A., C. Hoffmann, S.A. Sherrill-Mix, S.A. Keilbaugh, M. Hamady, Y.Y. Chen, R. Knight, R.S. Ahima, F. Bushman and G.D. Wu. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: 1716–1724.
• Jochym K., J. Kapusniak, R. Barczynska and K. Slizewska. 2012. New starch preparations resistant to enzymatic digestion. J. Sci. Food Agriculture 92(4): 886–891.
• Jumpertz R., D.S. Le, P.J. Turnbaugh, C. Trinidad, C. Bogardus, J.I. Gordon and J. Krakoff. 2011. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 94(1): 58–65.
• Keenan M.J., J. Zhou, K.L. McCutcheon, A.M. Raggio, H.G. Bateman, E. Todd, C.K. Jones, R.T. Tulley, S. Melton, R.J. Martin and others. 2006. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 14: 1523–1534.
• Kimura I., K. Ozawa, D. Inoue, T. Imamura,K. Kimura, T. Maeda, K. Terasawa,D. Kashihara, K. Hirano, T. Tani and others. 2013. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications 4: 1829.
• Kowalska-Duplaga K. 2003. Probiotics and prebiotics – the need to use or fashion? (in Polish) Świat Medycyny 10: 13–19.
• Lecerf J.M., F. Depeint, E. Clerc, Y. Dugenet, C.N. Niamba, L. Rhazi, A. Cayzeele, G. Abdelnour, A. Jaruga, H. Younes and others. 2012. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br. J. Nutr. 108: 1847–1858.
• Ley R.E., P. Turnbaugh, S. Klein and J.I. Gordon. 2006. Human gut microbes associated with obesity. Nature 444: 1022–1023.
• Libudzisz Z., M. Lewandowska and A. Gajek. 2012. Intestinal microorganisms of newborns and children (in Polish). Standardy medyczne/Pediatria 9: 100–109.
• Lin H.V., A. Frassetto, E.J. Kowalik, A.R. Nawrocki, M.M. Lu, J.R. Kosinski, J.A. Hubert, D. Szeto, X. Yao, G. Forrest and others. 2012. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. Plos ONE 7: 35240.
• Martínez I., J. Kim, P.R. Duffy, V.L. Schlegel and J. Walter. 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. Plos One 5: 15046.
• Murphy E.F., P.D. Cotter, S. Healy, T.M. Marques, O. O’Sullivan, F. Fouhy, S.F. Clarke, P.W. O’Toole, E.M. Quigley, C. Stanton and others. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59: 1635–1642.
• Moore T.A., C.K. Hanson and A. Anderson-Berry. 2011. Colonization of the gastrointestinal tract in neonates: a review Infant Child & Adolescent. Nutrition 3: 291–295.
• Neish A.S. 2002. The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect. 4: 309–317.
• Nicholson J.K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia and S. Pettersson. 2012. Host-gut microbiota metabolic interactions. Science 336: 1262–1267.
• Nowak A., K. Śliżewska, Z. Libudzisz and J. Socha. 2010. Probiotics-health effects (in Polish). ŻYWNOŚĆ Nauka Technologia Jakość 4(71): 20–36.
• Nowak A. and Z. Libudzisz. 2008. Human gut microbes (in Polish). Standardy medyczne/Pediatria 5: 372–379.
• Parnell J.A. and R.A. Reimer. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89(6): 1751–1759.
• Parnell J.A., M. Raman, K.P. Rioux and R.A. Reimer. 2012. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Internat. 32(5): 701–7011.
• Ramirez-Farias C., K. Slezak, Z. Fuller, A. Duncan, G. Holtrop and P. Louis. 2009. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 101: 541–550.
• Report WHO Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation GENEVA, 8–11 DECEMBER 2008.
• Report WHO Population-based prevention strategies for childhood obesity: report of a WHO forum and technical meeting, Geneva, 15–17 December 2009.
• Ridaura K.V., K. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, N.W. Griffin, V. Lombard, B. Henrissat, J.R. Bain and others. 2013. Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice. Science 341: 1241214.
• Russell W.R., S.W. Gratz, S.H. Duncan, G. Holtrop, J. Ince, L. Scobbie, G. Duncan, A.M. Johnstone, G.E. Lobley, R.J. Wallace and others. 2011. Highprotein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 93: 1062–1072.
• Salminen S. and E. Isolauri. 2006. Intestinal colonization, microbiota, and probiotics. J. Pediatr. 149: 115–120.
• Sanz Y. and A. Santacruz. 2008. Evidence on the role of gut microbes in obesity. Revista Espanola Obesidad 6: 256–263.
• Schwiertz A., D. Taras, K. Schafer, S. Beijer, N.A. Bos, C. Donus and P.D. Hardt. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18: 190–195.
• Shen J., M.S. Obin and L. Zhao. 2013. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34: 39–58.
• Stewar C.S., S.H. Duncan and D.R. Cave. 2004. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol. Lett. 230: 1–7.
• Scott K.P., S.W. Gratz, P.O. Sheridan, H.J. Flint and S.H. Duncan. 2013. The influence of diet on the gut mikrobiota. Pharmacol. Res. 69: 52–60.
• Tamboli C.P., C. Neut, P. Desreumaux and J.F. Colombel. 2004. Dysbiosis in inflammatory bowel disease. Gut Microbes 53: 1–4.
• Tarini J. and T.M. Wolever. 2010. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl. Physiol. Nutr. Metab. 35(1): 9–16.
• Tilg H. and A.R. Moschen. 2009. Obesity and the Microbiota. Gastroenterology 136: 1476–1483.
• Turnbaugh P.J., F. Backhed, L. Fulton and J.I. Gordon. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3: 213–223.
• Walker A.W., J. Ince, S.H. Duncan, L.M. Webster, G. Holtrop, X. Ze, D. Brown, M.D. Stares, P. Scott, A. Bergerat, P. Louis and others. 2011. Dominant and diet-responsive groups of bacteria within the human colonic mikrobiota. ISME Journal 5: 220–230.
• Walker A.W. and T.D. Lawley. 2013. Therapeutic modulation of intestinal dysbiosis. Pharmacol. Res. 69: 75–86.
• Walker A.W. and J.P. Fighting. 2013. Obesity with Bacteria. Science 341: 1069–1070.
• Wang Y. 2009. Prebiotics:present and future in food science and technology. Food Res. International 42: 8–12.
• Wu X., C. Ma, L. Han, M. Nawaz, F. Gao, X. Zhang, P. Yu, C. Zhao, L. Li, A. Zhou and others. 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61: 69–78.
• Wu G.D., J. Chen, C. Hoffmann, K. Bittinger, Y.Y. Chen, S.A. Keilbaugh, M. Bewtra, D. Knights, W.A. Walters, R. Knight and others. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105–108.
• Xu Q., Y.L. Chao and Q.B. Wan. 2009. Health benefit application of functional oligosaccharides. Carbohydr. Polym. 77: 435–441.